Therapeutic effect of post-exposure treatment with antiserum on severe fever with thrombocytopenia syndrome (SFTS) in a mouse model of SFTS virus infection

Virology

Volumn 482, Issue , 2015, Pages 19-27

  Shimada, Satoshi ^a   Posadas Herrera, Guillermo ^a,b   Aoki, Kotaro ^a   Morita, Kouichi ^a   Hayasaka, Daisuke ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Human antiserum; Mouse model; Post exposure prophylaxis; Ribavirin; Severe fever with thrombocytopenia syndrome

Indexed keywords

CIPROFLOXACIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MINOCYCLINE; PF 429242; PROTEINASE INHIBITOR; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; ANTIVIRUS AGENT; IMMUNOGLOBULIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; PHLEBOVIRUS; PHLEBOVIRUS INFECTION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROTECTION; SEVERE FEVER AND THROMBOCYTOPENIA SYNDROME; SEVERE FEVER AND THROMBOCYTOPENIA SYNDROME VIRUS; SURVIVAL TIME; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE; WEIGHT REDUCTION; ANIMAL; BUNYAVIRIDAE INFECTIONS; DISEASE MODEL; IMMUNOLOGY; PROCEDURES; SURVIVAL; TREATMENT OUTCOME;

MUS;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BUNYAVIRIDAE INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MICE; PHLEBOVIRUS; POST-EXPOSURE PROPHYLAXIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925870339     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.03.010     Document Type: Article

References (33)

1. Broker M., Kollaritsch H. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment. Vaccine 2008, 26:863-868.
2. Chen H., Hu K., Zou J., Xiao J. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis. 2013, 17:e206-e208.
3. Chen X.P., Cong M.L., Li M.H., Kang Y.J., Feng Y.M., Plyusnin A., Xu J., Zhang Y.Z. Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents. J. Gen. Virol. 2012, 93:1288-1293.
4. Dhingra A., Kapoor S., Alqahtani S.A. Recent advances in the treatment of hepatitis C. Discov. Med. 2014, 18:203-208.
5. Gai Z.T., Zhang Y., Liang M.F., Jin C., Zhang S., Zhu C.B., Li C., Li X.Y., Zhang Q.F., Bian P.F., Zhang L.H., Wang B., Zhou N., Liu J.X., Song X.G., Xu A., Bi Z.Q., Chen S.J., Li D.X. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J. Infect. Dis. 2012, 206:1095-1102.
6. IASR. 2013. http://www.nih.go.jp/niid/ja/sfts/sfts-iasrd/4021-kj4041.html.
7. Jin C., Liang M., Ning J., Gu W., Jiang H., Wu W., Zhang F., Li C., Zhang Q., Zhu H., Chen T., Han Y., Zhang W., Zhang S., Wang Q., Sun L., Liu Q., Li J., Wang T., Wei Q., Wang S., Deng Y., Qin C., Li D. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc. Natl. Acad. Sci. USA 2012, 109:10053-10058.
8. Keshtkar-Jahromi M., Kuhn J.H., Christova I., Bradfute S.B., Jahrling P.B., Bavari S. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antivir. Res. 2011, 90:85-92.
9. Khawplod P., Wilde H., Chomchey P., Benjavongkulchai M., Yenmuang W., Chaiyabutr N., Sitprija V. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14:389-391.
10. Kim K.H., Yi J., Kim G., Choi S.J., Jun K.I., Kim N.H., Choe P.G., Kim N.J., Lee J.K., Oh M.D. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg. Infect. Dis. 2013, 19:1892-1894.
11. Lange C.M., Jacobson I.M., Rice C.M., Zeuzem S. Emerging therapies for the treatment of hepatitis C. EMBO Mol. Med. 2014, 6:4-15.
12. Liu Q., He B., Huang S.Y., Wei F., Zhu X.Q. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect. Dis. 2014, 14:763-772.
13. Liu S., Chai C., Wang C., Amer S., Lv H., He H., Sun J., Lin J. Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev. Med. Virol. 2014, 24:90-102.
14. Liu W., Lu Q.B., Cui N., Li H., Wang L.Y., Liu K., Yang Z.D., Wang B.J., Wang H.Y., Zhang Y.Y., Zhuang L., Hu C.Y., Yuan C., Fan X.J., Wang Z., Zhang L., Zhang X.A., Walker D.H., Cao W.C. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin. Infect. Dis.: Offic. Publ. Infect. Dis. Soc. Am. 2013, 57:1292-1299.
15. Liu Y., Li Q., Hu W., Wu J., Wang Y., Mei L., Walker D.H., Ren J., Yu X.J. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis. 2012, 12:156-160.
16. Liu Y., Wu B., Paessler S., Walker D.H., Tesh R.B., Yu X.J. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J. Virol. 2014, 88:1781-1786.
17. Mahara F. Japanese spotted fever: report of 31 cases and review of the literature. Emerg. Infect. Dis. 1997, 3:105-111.
18. Mair-Jenkins J., Saavedra-Campos M., Baillie J.K., Cleary P., Khaw F.M., Lim W.S., Makki S., Rooney K.D., Beck C.R. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J. Infect. Dis. 2015, 211:80-90.
19. McCormick J.B., King I.J., Webb P.A., Scribner C.L., Craven R.B., Johnson K.M., Elliott L.H., Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 1986, 314:20-26.
20. Mupapa K., Massamba M., Kibadi K., Kuvula K., Bwaka A., Kipasa M., Colebunders R., Muyembe-Tamfum J.J. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 1999, 179(Suppl 1):S18-S23.
21. Oh W.S., Heo S.T., Kim S.H., Choi W.J., Han M.G., Kim J.Y. Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome. Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis. 2014, 18:84-86.
22. Olmstead A.D., Knecht W., Lazarov I., Dixit S.B., Jean F. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog. 2012, 8:e1002468.
23. Pasquato A., Rochat C., Burri D.J., Pasqual G., de la Torre J.C., Kunz S. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. Virology 2012, 423:14-22.
24. Shimojima M., Fukushi S., Tani H., Yoshikawa T., Fukuma A., Taniguchi S., Suda Y., Maeda K., Takahashi T., Morikawa S., Saijo M. Effects of ribavirin on severe Fever with thrombocytopenia syndrome virus in vitro. Jpn. J. Infect. Dis. 2014, 67:423-427.
25. Sidwell R.W., Barnard D.L. Respiratory syncytial virus infections: recent prospects for control. Antivir. Res. 2006, 71:379-390.
26. Takahashi T., Maeda K., Suzuki T., Ishido A., Shigeoka T., Tominaga T., Kamei T., Honda M., Ninomiya D., Sakai T., Senba T., Kaneyuki S., Sakaguchi S., Satoh A., Hosokawa T., Kawabe Y., Kurihara S., Izumikawa K., Kohno S., Azuma T., Suemori K., Yasukawa M., Mizutani T., Omatsu T., Katayama Y., Miyahara M., Ijuin M., Doi K., Okuda M., Umeki K., Saito T., Fukushima K., Nakajima K., Yoshikawa T., Tani H., Fukushi S., Fukuma A., Ogata M., Shimojima M., Nakajima N., Nagata N., Katano H., Fukumoto H., Sato Y., Hasegawa H., Yamagishi T., Oishi K., Kurane I., Morikawa S., Saijo M. The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J. Infect. Dis. 2014, 209:816-827.
27. Tang X., Wu W., Wang H., Du Y., Liu L., Kang K., Huang X., Ma H., Mu F., Zhang S., Zhao G., Cui N., Zhu B.P., You A., Chen H., Liu G., Chen W., Xu B. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J. Infect. Dis. 2013, 207:736-739.
28. Urata S., Yun N., Pasquato A., Paessler S., Kunz S., de la Torre J.C. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J. Virol. 2011, 85:795-803.
29. Wang Y., Deng B., Zhang J., Cui W., Yao W., Liu P. Person-to-person asymptomatic infection of severe fever with thrombocytopenia syndrome virus through blood contact. Intern. Med. 2014, 53:903-906.
30. Yamaguchi Prefectural Surveillance Center of Infectious Disease. 2015. http://kanpoken.pref.yamaguchi.lg.jp/jyoho/page9/sfts_1.php.
31. Yoshikawa T., Fukushi S., Tani H., Fukuma A., Taniguchi S., Toda S., Shimazu Y., Yano K., Morimitsu T., Ando K., Yoshikawa A., Kan M., Kato N., Motoya T., Kuzuguchi T., Nishino Y., Osako H., Yumisashi T., Kida K., Suzuki F., Takimoto H., Kitamoto H., Maeda K., Takahashi T., Yamagishi T., Oishi K., Morikawa S., Saijo M., Shimojima M. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J. Clin. Microbiol. 2014, 52:3325-3333.
32. Yu X.J., Liang M.F., Zhang S.Y., Liu Y., Li J.D., Sun Y.L., Zhang L., Zhang Q.F., Popov V.L., Li C., Qu J., Li Q., Zhang Y.P., Hai R., Wu W., Wang Q., Zhan F.X., Wang X.J., Kan B., Wang S.W., Wan K.L., Jing H.Q., Lu J.X., Yin W.W., Zhou H., Guan X.H., Liu J.F., Bi Z.Q., Liu G.H., Ren J., Wang H., Zhao Z., Song J.D., He J.R., Wan T., Zhang J.S., Fu X.P., Sun L.N., Dong X.P., Feng Z.J., Yang W.Z., Hong T., Zhang Y., Walker D.H., Wang Y., Li D.X. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med. 2011, 364:1523-1532.
33. Zhang Y.Z., Zhou D.J., Qin X.C., Tian J.H., Xiong Y., Wang J.B., Chen X.P., Gao D.Y., He Y.W., Jin D., Sun Q., Guo W.P., Wang W., Yu B., Li J., Dai Y.A., Li W., Peng J.S., Zhang G.B., Zhang S., Chen X.M., Wang Y., Li M.H., Lu X., Ye C., de Jong M.D., Xu J. The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J. Virol. 2012, 86:2864-2868.